EUVIMED · CrossrefZeitschrift
RSC Medicinal Chemistry
ISSN 2632-8682 · Royal Society of Chemistry (RSC)
Neueste Artikel
Structure–activity relationship of GSK-3β inhibitors: insight into drug design for Alzheimer's disease
2-Oxoindolin-thiazoline hybrids as scaffold-based therapeutics for T2DM-associated cognitive impairment: design, synthesis, in vitro and in silico studies
An exploration of potent antileishmanial agents derived from quinoline–thiazole and thiadiazole hybrids, targeting DHFR-TS and PTR1: design, synthesis, and computational analyses
Evaluating the FEP+ protocol for predicting binding affinity of congeneric ligands towards various soluble proteins
Design, synthesis, and anticancer evaluation of novel pyrrole–pyrazoline/chalcone hybrids: in vitro and computational insights into EGFR inhibition
Recent advances in the antimicrobial potential of boron cluster compounds
Integrating green synthesis and liquid–liquid extraction of lidocaine in deep eutectic solvents
Ferrocenyl ferroptosis inducers as an emerging class of anticancer agents: a mini review
N -Cyano sulfoximine-mediated thiazole ligation with N -terminal cysteine under mild aqueous conditions
Empowering molecular complexity via biocatalysis: emerging blueprints in the total synthesis of medicinally relevant natural products
Revealing deamidation and isoaspartate formation during peptide analysis, purification and storage by tandem mass spectrometry
Adamantane-based inhibitors of the influenza A M2 proton channel: structure-based design, biological evaluation, and synthetic approaches
Bisarylthiourea comprising cycloalkyl-thiophene-3-carboxylate derivatives as potential human toll-like receptor (TLR2) agonists: design, synthesis, and structure–activity relationship enabling the switch from TLR2/1 to TLR2/6 activation
Sulfone and sulfoxide-containing pharmaceuticals: targets, pharmacological properties and SAR studies
Recent advances towards BACE1 drug discovery and therapeutics design
1,3,4-Oxadiazole derivatives: targeting multiple bacterial pathways
Recent advances in the development of acridine-based hybrids with antiproliferative activity
d -Galactose-conjugated pyrimidine thioureas as potent antimicrobial agents: rapid green synthesis, structure–activity relationships and molecular modelling
Pharmacological landscape of carbolines: a holistic view
Histone deacetylase-based dual inhibitors: research progress focusing on non-small cell lung cancer therapy
Diverse ring architectures of cyclic peptidomimetics targeting melanocortin receptors
Addressing multidrug-resistant bacterial infections with iridium-based theragnostic agents
Inhibition effects and binding behavior of alginate oligosaccharides on tyrosinase and elastase: multi-spectroscopic approaches and zebrafish evaluation
Emerging cellular uptake mechanisms of bRo5 PROTACs
Design, synthesis, and biological evaluation of novel SN38–sulfonamide conjugates as Topo I/CA IX dual inhibitors inducing ferroptosis in colorectal cancer
Integrated 3D-QSAR, molecular docking, molecular dynamics, DFT, in vitro , and in vivo evaluation of benzylidene-thiazolidinedione derivatives as aldose reductase inhibitors
Novel triazolo[1,5]benzodiazepines as potent dual AChE/BChE inhibitors for Alzheimer's disease: synthesis, characterization, in vitro and in silico studies
Benzoxazole–benzamide hybrids: synthesis, structure–activity relationships, and multi-biological evaluation
Synthesis, biological evaluation, and in silico studies of paracetamol-derived 4-hydroxyphenylamino-pyridine conjugates as analgesic agents
Development of phenothiazine-based inhibitors towards drug-resistant glioblastoma
EUVIMED